1. Home
  2. ADPT vs KARO Comparison

ADPT vs KARO Comparison

Compare ADPT & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$15.41

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Karooooo Ltd.

KARO

Karooooo Ltd.

HOLD

Current Price

$46.95

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
KARO
Founded
2009
2001
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
1.4B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
ADPT
KARO
Price
$15.41
$46.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
4
Target Price
$16.60
$58.25
AVG Volume (30 Days)
3.0M
40.0K
Earning Date
11-05-2025
01-13-2026
Dividend Yield
N/A
2.69%
EPS Growth
N/A
18.61
EPS
N/A
1.82
Revenue
$252,754,000.00
$282,977,939.00
Revenue This Year
$50.81
$21.18
Revenue Next Year
$1.17
$15.95
P/E Ratio
N/A
$25.52
Revenue Growth
42.57
14.75
52 Week Low
$5.81
$35.88
52 Week High
$20.76
$63.36

Technical Indicators

Market Signals
Indicator
ADPT
KARO
Relative Strength Index (RSI) 44.33 53.59
Support Level $14.58 $44.44
Resistance Level $16.26 $48.11
Average True Range (ATR) 1.13 1.41
MACD -0.36 0.46
Stochastic Oscillator 13.75 72.74

Price Performance

Historical Comparison
ADPT
KARO

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.

Share on Social Networks: